What are the risks of Methiopropamine?

Acute Toxicity No formal human toxicological studies exist for MPA. Based on its mechanism (selective NDRA) and community UK experience: Cardiovascular stimulation (tachycardia, hypertension) is the primary acute risk The norepinephrine-dominant profile may produce more pronounced cardiovascular eff

Methiopropamine — SubstanceWiki

Methiopropamine

Thiophene · Stimulants

8 dangerous interactions — combining Methiopropamine with certain substances may be life-threatening.

See all

Stimulants(Thiophene)

Quick Dosage

insufflated20–40 mg (common)

oral30–50 mg (common)

View full details

Methiopropamine (MPA; 1-(thiophen-2-yl)-2-methylaminopropane) is a synthetic stimulant of the thiophene chemical class — a structural analog of methamphetamine in which the phenyl ring is replaced by a thiophene ring (a five-membered aromatic ring containing one sulfur atom). This bioisosteric substitution — replacing benzene with thiophene while retaining the overall molecular framework — represents a classic medicinal chemistry approach to modulating pharmacological properties.

MPA acts as a selective norepinephrine-dopamine releasing agent with approximately one-third the norepinephrine reuptake inhibitor potency and one-seventh the dopamine reuptake inhibitor potency of methamphetamine, making it substantially less potent overall. Community experience describes its effects as lighter and shorter-acting than methamphetamine — a mild to moderate stimulant producing wakefulness, motivation, and modest mood elevation without the intense euphoria of methamphetamine. Duration is typically 3–5 hours, shorter than methamphetamine analogs.

MPA achieved a period of mainstream visibility in the UK "legal high" market around 2009–2013, marketed in products as a "legal methamphetamine alternative" before being explicitly scheduled. It was one of the earlier research chemical stimulants to develop substantial community harm reduction documentation in UK-centric drug forums. Despite its lower potency, MPA is not without risk: it carries standard stimulant cardiovascular and dependence risks, and its thiophene ring raises theoretical questions about reactive metabolite formation — a concern with thiophene-containing drugs generally.

How It Feels

Methiopropamine arrives with the quiet competence of a functional stimulant that knows its place. Within twenty to forty minutes of oral ingestion, or somewhat faster when insufflated, a calm alertness begins to establish itself. Fatigue recedes. Focus sharpens. There is a mild increase in motivation and a subtle but genuine sense that tasks are more approachable than they were half an hour ago. The onset is unremarkable in its smoothness, offering none of the dramatic rush or euphoria that characterizes recreational stimulants.

At its functional peak, typically reached within an hour, methiopropamine produces a state of enhanced concentration and sustained attention. The mind locks onto tasks with a pleasant efficiency. Distractibility decreases, and there is an ability to work through material that would ordinarily provoke boredom or avoidance. The mood lifts slightly, though the elevation is subtle enough that it might be attributed to the satisfaction of getting things done rather than to any direct pharmacological warmth. Social interactions feel slightly easier, and there is a mild increase in verbal fluency, but the compound is not social in the way that more serotonergic stimulants are. This is a tool for work, not for parties.

Physical effects are mild and manageable. Heart rate increases modestly. Appetite is suppressed. There may be a slight dryness of the mouth and a barely perceptible tremor in the hands. The overall physical load is light, making methiopropamine one of the more physically comfortable stimulants in its class. There is none of the aggressive vasoconstriction, jaw clenching, or temperature dysregulation that accompanies more potent compounds. The body feels alert but not strained.

The effects last three to six hours, tapering gradually and without drama. The comedown is gentle, characterized by a slow return of fatigue and normal distractibility rather than any acute crash or emotional deficit. Sleep is achievable within a few hours of the effects wearing off. The following morning feels normal. The overall experience is defined by its unremarkable competence, a substance that does what a functional stimulant should do and nothing more. It lacks the glamour, the danger, and the recreational potential of more potent compounds, and for its intended purpose, this absence is a feature rather than a flaw.

Subjective Effects

The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.

Physical Effects

Physical(7)

Appetite suppression— A distinct decrease in hunger and desire to eat, ranging from reduced interest in food to complete d...
Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Teeth grinding— An involuntary clenching and rhythmic grinding of the jaw muscles, known clinically as bruxism, that...
Vasoconstriction— A narrowing of blood vessels throughout the body that produces sensations of cold extremities, tingl...

Tactile(1)

Spontaneous tactile sensations— Unprompted physical sensations that arise without external touch or stimulus, manifesting as tinglin...

Cognitive & Perceptual Effects

Cognitive(12)

Analysis enhancement— A perceived improvement in one's ability to logically deconstruct concepts, recognize patterns, and ...
Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
Cognitive euphoria— A cognitive and emotional state of intense well-being, elation, happiness, and joy that manifests as...
Cognitive fatigue— Mental exhaustion and difficulty sustaining thought after intense cognitive experiences, common duri...
Compulsive redosing— An overwhelming, difficult-to-resist urge to continuously take more of a substance in order to maint...

Interactions

Substance	Status	Note
25x-NBOH	Dangerous	—
25x-NBOMe	Dangerous	—
Atropa belladonna	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Datura	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Diphenhydramine	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Harmala alkaloid	Dangerous	Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Peganum harmala	Dangerous	Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
MDMA	Unsafe	—
1,3-Butanediol	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25E-NBOH	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-2	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-21	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-7	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
3-FMA	Caution	Increased cardiovascular strain and neurotoxicity risk
4-MMC	Caution	Increased cardiovascular strain and neurotoxicity risk
8-Chlorotheophylline	Caution	Increased cardiovascular strain and neurotoxicity risk
Adrafinil	Caution	Increased cardiovascular strain and neurotoxicity risk
Allylescaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Ayahuasca	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Benzydamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Bromantane	Caution	Increased cardiovascular strain and neurotoxicity risk
Cake	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Deschloroetizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Desomorphine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
DET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Dichloropane	Caution	Increased cardiovascular strain and neurotoxicity risk
Diclazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
DiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DOM	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Efavirenz	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Ephedrine	Caution	Increased cardiovascular strain and neurotoxicity risk
EPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Eszopiclone	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Etizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flubromazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flubromazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flunitrazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flunitrazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Gaboxadol	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Hexedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
Ibogaine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Lorazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Mephenaqualone	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
MET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methallylescaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methcathinone	Caution	Increased cardiovascular strain and neurotoxicity risk
Metizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Midazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
MiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
MPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Naloxone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Nicotine	Caution	Increased cardiovascular strain and neurotoxicity risk
Nifoxipam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Oxiracetam	Caution	Increased cardiovascular strain and neurotoxicity risk
Pentobarbital	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Phenobarbital	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Phenylpiracetam	Caution	Increased cardiovascular strain and neurotoxicity risk
Psilocybin Mushrooms	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Rhodiola Rosea	Caution	Increased cardiovascular strain and neurotoxicity risk
SAMe	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Alcohol	Uncertain	—

Showing 63 key interactions out of 64 total.

Toxicity & Safety

Acute Toxicity

No formal human toxicological studies exist for MPA. Based on its mechanism (selective NDRA) and community UK experience:

Cardiovascular stimulation (tachycardia, hypertension) is the primary acute risk
The norepinephrine-dominant profile may produce more pronounced cardiovascular effects relative to euphoria than dopamine-dominant compounds

Thiophene Reactive Metabolite Concern

A theoretical but pharmacologically relevant concern: some thiophene-containing drugs (methapyrilene, tienilic acid) are associated with hepatotoxicity via CYP450-mediated formation of reactive thiophene metabolites (S-oxides, epoxides). Whether MPA produces such metabolites and at what doses this is relevant is unknown. This is not an established clinical finding for MPA specifically but represents a mechanistic concern for chronic or heavy use.

Cardiovascular Risk

Given its norepinephrine-dominant releasing agent activity, MPA may produce more cardiovascular activation (tachycardia, hypertension) relative to its subjective euphoria than dopaminergic stimulants. Users seeking more intense effects may overdose relative to what the euphoric component indicates.

UK Adverse Events

During the UK "legal high" era (2009–2013), MPA was associated with adverse events including cardiovascular presentations and psychiatric crises — though the contribution of MPA vs. adulterants in legal high products makes attribution complex. The UK Forensic Science Service documented MPA in "NRG-1" and similar products.

Dependence

As a dopamine/norepinephrine releasing agent, MPA carries stimulant dependence potential, though lower potency than methamphetamine likely reduces compulsive use drive.

Addiction Potential

moderately addictive with a high potential for abuse

Overdose Information

Stimulant overdose from Methiopropamine is a medical emergency primarily involving cardiovascular and neurological toxicity.

Signs of overdose: Extremely rapid or irregular heartbeat, chest pain, severe headache, dangerously elevated body temperature, seizures, agitation progressing to psychosis, confusion, and loss of consciousness.Emergency response:

Call emergency services immediately
Keep the person cool (remove excess clothing, apply cool water)
If seizures occur, protect the head and clear the area of hard objects
If the person loses consciousness, place in recovery position
Do not give the person more stimulants, caffeine, or depressants unless directed by medical professionalsPrevention: Pre-measure doses. Avoid redosing. Stay hydrated (but don't overhydrate). Take breaks from physical activity. Monitor heart rate if possible. Have someone present who can recognize warning signs.

Full	develops with prolonged and repeated use
Half	3 - 7 days
Zero	1 - 2 weeks

Methiopropamine

Quick Dosage

Dosage

insufflated

oral

Duration

oral

How It Feels

Subjective Effects

Physical Effects

Physical(7)

Tactile(1)

Cognitive & Perceptual Effects

Cognitive(12)

Pharmacology

Mechanism of Action

Receptor Profile

Pharmacokinetics

Thiophene Bioisosterism

Detection Methods

Standard Drug Panel Inclusion

Urine Detection

Blood and Saliva Detection

Hair Follicle Detection

Confirmatory Testing

Reagent Testing

Interactions

History

Synthesis and Early History

UK Legal High Era (2009–2013)

Scheduling

Legacy

Harm Reduction

Lower Potency Does Not Mean Safer

Dose Reference

Insufflation Risk

Thiophene Concern — Monitor Liver

Do Not Combine with MAOIs

Legal High Context Caution

Toxicity & Safety

Acute Toxicity

Thiophene Reactive Metabolite Concern

Cardiovascular Risk

UK Adverse Events

Dependence

Addiction Potential

Overdose Information

Dangerous Interactions

Tolerance

Cross-tolerances

Legal Status

Experience Reports (2)

Tips (4)

See Also

References (5)

Frequently Asked Questions